Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kerala AyurvedaBOM:530163 -0.77%47 Days Inventory is 175.51 as of Mar. 2026, which is 24% below its 10-year median of 229.65. GuruFocus rates BOM:530163 with a GF Score™ of 47/100 and a GF Value™ of ₹319.99 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 921 Drug Manufacturers companies, Kerala Ayurveda ranks worse than 58.96% on this metric.
The historical rank and industry rank for Kerala Ayurveda's Days Inventory or its related term are showing as below:
BOM:530163'
s Days Inventory Range Over the Past 10 Years
Min: 155.93 Med: 229.65 Max: 258.06
Current: 186.45
During the past 13 years, Kerala Ayurveda's highest Days Inventory was 258.06. The lowest was 155.93. And the median was 229.65.
BOM:530163's Days Inventory is ranked worse than 58.96% of 921
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs BOM:530163: 186.45
Kerala Ayurveda's Days Inventory
declined
from Mar. 2025 (211.68) to Mar. 2026 (175.51).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Kerala Ayurveda's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.52.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Kerala Ayurveda's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.43.
Kerala Ayurveda (BOM:530163) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Kerala Ayurveda's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Kerala Ayurveda's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Kerala Ayurveda Days Inventory Related Terms
Kerala Ayurveda Days Inventory Historical Data
* Premium members only.
The historical data trend for Kerala Ayurveda's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:530163 vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Kerala Ayurveda's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kerala Ayurveda Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kerala Ayurveda's Days Inventory distribution charts can be found below:
* The bar in red indicates where Kerala Ayurveda's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kerala Ayurveda (BOM:530163) has a Days Inventory of 175.51 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Kerala Ayurveda and its competitors. This is 24% below median its historical median of 229.65. Over the past decade, Kerala Ayurveda's Days Inventory has ranged from 155.93 to 258.06. According to the industry distribution chart, Kerala Ayurveda ranks #543 out of 921 companies in the Drug Manufacturers industry, placing it in the top 59%.
Is Kerala Ayurveda's Days Inventory too high?
Kerala Ayurveda's current Days Inventory of 175.51 is 24% below median its 10-year median of 229.65. Over the past 10 years, this metric has ranged from a low of 155.93 to a high of 258.06. The Drug Manufacturers industry median Days Inventory is 164.48. Kerala Ayurveda's value of 175.51 is 6.7% above this industry median. Based on the distribution chart, Kerala Ayurveda ranks #543 out of 921 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Kerala Ayurveda has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kerala Ayurveda's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kerala Ayurveda ranks #543 out of 921 companies for Days Inventory. This places Kerala Ayurveda in the lower half of its industry. The industry median Days Inventory is 164.48. Kerala Ayurveda's value of 175.51 is 6.7% above this benchmark. Historically, Kerala Ayurveda's own Days Inventory has ranged from 155.93 to 258.06 over the past decade. While the company's 10-year median is 229.65 vs. the industry median of 164.48, Kerala Ayurveda has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kerala Ayurveda's current Days Inventory of 175.51 is 6.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Kerala Ayurveda and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kerala Ayurveda's current Days Inventory is 175.51, which is 24% below median its own 10-year median of 229.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kerala Ayurveda stock overvalued right now?
Based on GuruFocus' analysis, Kerala Ayurveda (BOM:530163) is currently considered Possible Value Trap. The stock's GF Value™ is ₹319.99, compared to a current price of ₹155.00 — trading 51.6% below its estimated fair value. The current Days Inventory is 175.51, which is 24% below median its 10-year median of 229.65 and 6.7% above the Drug Manufacturers industry median of 164.48. Kerala Ayurveda's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Kerala Ayurveda (BOM:530163), the current Days Inventory is 175.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kerala Ayurveda (BOM:530163) Overvalued in 2026?
Based on GuruFocus' analysis, Kerala Ayurveda stock appears to be undervalued.
The current stock price of ₹155.00 is trading 51.6% below its estimated GF Value™ of ₹319.99.
GuruFocus considers Kerala Ayurveda to be Possible Value Trap.
Key valuation signals for BOM:530163:
Days Inventory: 175.51 (24% below median its 10-year median of 229.65)
GF Value™: ₹319.99 vs. price of ₹155.00 (51.6% below fair value)
Industry Position: 6.7% above the Drug Manufacturers median (#543 of 921)
No single metric tells the full story. See the BOM:530163 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kerala Ayurveda Ltd is engaged in producing and selling ayurvedic products and providing healthcare services. The company offers ayurvedic medicine products for diabetes and heart health, skin and hair care, kids' health, women's care, men's care, gastro care, respiratory and allergy, general healthcare, massage oils, renal care, and joint care. It provides services through wellness clinics, resorts, hospitals, and academies. The company has only one reportable business segment, i.e., Full-spectrum Ayurvedic wellness. It generates maximum revenue from the sale of products. Geographically, the company generates maximum revenue from its business in India and also has some exposure to other markets.
47GF Score
Get the complete analysis for BOM:530163
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530163 has been successfully added to your 
